Consolidated Condensed Statements of Equity - USD ($) $ in Thousands		Total	Controlling Member	Noncontrolling Interest
Balance, January 1 at Dec. 31, 2015		$ 2,639,586	$ 2,344,155	$ 295,431
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income/(loss)		180,788	172,202	8,586
Other comprehensive income/(loss)	[1]	53,364	53,364	0
Comprehensive income/(loss)		234,152	225,566	8,586
Cash dividends declared:
Preferred stock ($4,650 per share for the nine months ended September 30, 2017 and 2016)		(4,650)	(4,650)	0
Common stock ($.27 and $.21 per share for the nine months ended September 30, 2017 and 2016, respectively)		(49,578)	(49,578)	0
Common stock repurchased	[2]	(96,801)	(96,801)	0
Common stock issued for:
Stock options and restricted stock - equity awards		18,710	18,710	0
Stock-based compensation expense		12,378	12,378	0
Dividends declared - noncontrolling interest of subsidiary preferred stock		(8,586)	0	(8,586)
Tax benefit/(benefit reversal) - stock based compensation expense		(629)	(629)	0
Balance, September 30 at Sep. 30, 2016		2,744,582	2,449,151	295,431
Balance, January 1 at Dec. 31, 2016		2,705,084	2,409,653	295,431
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income/(loss)		225,361	216,806	8,555
Other comprehensive income/(loss)	[1]	15,270	15,270	0
Comprehensive income/(loss)		240,631	232,076	8,555
Cash dividends declared:
Preferred stock ($4,650 per share for the nine months ended September 30, 2017 and 2016)		(4,650)	(4,650)	0
Common stock ($.27 and $.21 per share for the nine months ended September 30, 2017 and 2016, respectively)		(63,777)	(63,777)	0
Common stock repurchased	[2]	(5,285)	(5,285)	0
Common stock issued for:
Stock options and restricted stock - equity awards		5,132	5,132	0
Stock-based compensation expense		14,971	14,971	0
Dividends declared - noncontrolling interest of subsidiary preferred stock		(8,555)	0	(8,555)
Tax benefit/(benefit reversal) - stock based compensation expense		0	0	0
Balance, September 30 at Sep. 30, 2017		$ 2,883,551	$ 2,588,120	$ 295,431

[1] Due to the nature of the preferred stock issued by FHN and its subsidiaries, all components of Other comprehensive income/(loss) have been attributed solely to FHN as the controlling interest holder.

[2] 2016 includes $93.5 million repurchased under share repurchase programs.